Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7,134 INR | -0.14% | -5.39% | +34.93% |
05-10 | Neuland Laboratories' Consolidated Profit Declines in Fiscal Q4 | MT |
05-10 | Neuland Laboratories Limited Recommends Final Dividend for the Financial Year 2023-24 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+34.93% | 1.1B | |
+30.38% | 684B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.70% | 240B | |
+8.78% | 208B | |
-7.93% | 200B | |
+7.68% | 166B |
- Stock Market
- Equities
- NEULANDLAB Stock
- News Neuland Laboratories Limited
- Crisil Raises Neuland Laboratories Rating to A; Outlook Stable